Page last updated: 2024-08-21

oxazoles and Libman-Sacks Disease

oxazoles has been researched along with Libman-Sacks Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fagone, P; Kim, JJ; Magro, G; Mangano, K; Meroni, PL; Muthumani, K; Nicoletti, F; Sardesai, NY; Weiner, DB1
Lee, S; Moon, EY; Yi, KY1
Han, SH; Kim, HS; Lee, GH; Lee, S; Moon, EY; Oh, JM; Yang, Y; Yi, KY; Yoon, WK1
Bartlett, RR; Popovic, S1
Eldredge, NT; Jiller, JJ; van Robertson, WB1

Other Studies

5 other study(ies) available for oxazoles and Libman-Sacks Disease

ArticleYear
VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus.
    Immunology, 2014, Volume: 142, Issue:4

    Topics: Acetates; Animals; Disease Models, Animal; Female; Humans; Immunologic Factors; Lipopolysaccharides; Lupus Erythematosus, Systemic; Male; Mice; Oxazoles; Toll-Like Receptor 4

2014
An increase in B cell apoptosis by interfering BAFF-BAFF-R interaction with small synthetic molecules.
    International immunopharmacology, 2011, Volume: 11, Issue:10

    Topics: Animals; Apoptosis; B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Lymphocytes; CD8 Antigens; Cell Line; Cell Separation; Drug Evaluation, Preclinical; Flow Cytometry; Guanidines; Humans; Lipopolysaccharides; Lupus Erythematosus, Systemic; Mice; Oxazoles; Protein Binding; Recombinant Fusion Proteins; Signal Transduction

2011
KR33426, [2-(2,5-dichlorophenyl)-5-methyloxazol-4yl]carbonylguanidine, is a novel compound to be effective on mouse systemic lupus erythematosus.
    European journal of pharmacology, 2011, Oct-15, Volume: 668, Issue:3

    Topics: Animals; Apoptosis; B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Lymphocytes; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Guanidines; Lupus Erythematosus, Systemic; Mice; Oxazoles; Spleen

2011
Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.
    Agents and actions, 1986, Volume: 19, Issue:5-6

    Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Oxazoles

1986
The interaction of lupus-inducing drugs with deoxyribonucleic acid.
    Clinical immunology and immunopathology, 1974, Volume: 3, Issue:2

    Topics: Adult; Animals; Cattle; Child; DNA; DNA, Single-Stranded; Hot Temperature; Humans; Hydralazine; Immunodiffusion; Isoniazid; Lupus Erythematosus, Systemic; Methyldopa; Nucleic Acid Conformation; Nucleic Acid Denaturation; Optical Rotation; Oxazoles; Phenytoin; Procainamide; Propylthiouracil; Thymus Gland; Trimethadione; Viscosity

1974